is farxiga a glp-1 Side Effects: What to Expect and How to Manage MCT2D | The Benefits of
Description
J Lipid Res 1995;36:211-28.ArticlePubMed 79
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have multiple glycaemic and nonglycaemic benefits in patients with type 2 diabetes, including reduced glycaemia, mortality, cardiovascular events and weight
One study reported that 43.8% of participants who discontinued treatment did so due to nausea and vomiting, while 36.8% stopped because of gastrointestinal discomfort [14]
, Zanella, D
